← Back to Search

Virtual Yoga for Insomnia in Cancer Survivors

N/A
Waitlist Available
Led By Karen Mustian, PhD, MPH
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Cancer Survivors must score ≥4 on a 0-10 sleep screening scale
Cancer Survivors must have a confirmed diagnosis of cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to week 5
Awards & highlights

Study Summary

This trial is examining whether a four-week yoga intervention delivered virtually is effective in improving insomnia and sleep quality in cancer survivors.

Who is the study for?
This trial is for cancer survivors who've finished their surgery, chemo, or radiation between 2 months and 10 years ago. They must have trouble sleeping, be over 18, speak English, and can use the internet with a device. They shouldn't have sleep apnea or restless leg syndrome, be doing yoga already or plan to start it outside of the study.Check my eligibility
What is being tested?
The study tests if virtual YOCAS©® yoga helps improve sleep in cancer survivors compared to standard care. Participants are randomly placed into two groups: one does four weeks of online yoga sessions; the other continues regular care without yoga.See study design
What are the potential side effects?
Yoga is generally safe but may include risks like muscle strains or falls for some individuals. Since this is not a drug trial, side effects are minimal compared to medicinal interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I often have trouble sleeping.
Select...
I have a confirmed cancer diagnosis.
Select...
I can read and understand English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to week 5
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 5 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Malignant Neoplasms
Secondary outcome measures
Malignant Neoplasms

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: YOCASExperimental Treatment1 Intervention
Cancer survivors receive 8 virtual yoga sessions (75 minutes/session, 2 times a week for 4 weeks) delivered via an electronic platform (e.g., Zoom)
Group II: Standard CareActive Control1 Intervention
Cancer survivors receive their standard care

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
836 Previous Clinical Trials
518,126 Total Patients Enrolled
7 Trials studying Insomnia
1,846 Patients Enrolled for Insomnia
Bassett Medical CenterOTHER
Karen Mustian, PhD, MPHPrincipal Investigator - University of Rochester
University of Rochester

Media Library

YOCAS©® yoga Clinical Trial Eligibility Overview. Trial Name: NCT04458194 — N/A
Insomnia Research Study Groups: Standard Care, YOCAS
Insomnia Clinical Trial 2023: YOCAS©® yoga Highlights & Side Effects. Trial Name: NCT04458194 — N/A
YOCAS©® yoga 2023 Treatment Timeline for Medical Study. Trial Name: NCT04458194 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being taken into this medical trial?

"Yes, the information on clinicaltrials.gov validates that this research trial is currently recruiting. It was initially published on December 1st 2022 and had its most recent update on January 25th 2022. The study has 2 sites where 42 participants are being sought after."

Answered by AI

What is the intended outcome of this research?

"The primary endpoint of this clinical trial, which will be evaluated from baseline to week 5, is the Mean shift in insomnia as documented by Insomnia Severity Index (ISI) overall score between caregivers who receive Partnered YOCAS compared to Standard Care. Secondary objectives include gauging a divergence in sleep quality among cancer survivors with the help of Pittsburgh Sleep Quality Inventory (PSQI) total Score; linear mixed effects ANCOVA will assess the variance in mean change when comparing those receiving Partnered YOCAS vs. those on Standard Care and Non-partnered YOCAS respectively. Likewise, PSQI scores will also be"

Answered by AI

Are researchers currently recruiting volunteers for this experiment?

"According to information posted on clinicaltrials.gov, this trial is open for enrollment and was first published in December of 2022 with a recent update made at the end of January."

Answered by AI
~13 spots leftby Apr 2025